Madsen Julia
Sr. VP and GM, Life Sciences at STE
- Sold, on record
- $3.1M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Nov 21, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STESTERIS plcSr. VP and GM, Life Sciences
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STEUnusualNov 9 2020
Sold 1,900 shares at $192.44 ($366k)
Madsen Julia, Senior VP, Life Sciences
Sold 29% of holdings ($1.3M position)4,641 shares leftFirst sale on recordFiling
- 2 Form 4 sale STEPlan not statedJan 8 +60 days
Sold 1,000 shares at $202.00 ($202k)
Madsen Julia, Senior VP, Life Sciences
Sold 17.7% of holdings ($1.1M position)4,641 shares leftFiling
- 3 Form 4 sale STEPlan not statedApr 20 +102 days
Sold 1,000 shares at $210.00 ($210k)
Madsen Julia, Senior VP, Life Sciences
Sold 17.7% of holdings ($1.2M position)4,641 shares leftFiling
- 4 Form 4 sale STEPlan not statedApr 23 +3 days
Sold 1,000 shares at $215.00 ($215k)
Madsen Julia, Senior VP, Life Sciences
Sold 17.7% of holdings ($1.2M position)4,641 shares left1x usual sizeFiling
- 5 Form 4 sale STEUnusualJun 5 +1139 days
Sold 3,652 shares at $230.00 ($840k)
Madsen Julia, Senior VP, Life Sciences
No 10b5-1 planSold 27.4% of holdings ($3.1M position)9,671 shares leftFirst sale on recordFiling
- 6 Form 4 sale STEUnusualNov 21 +534 days
Sold 5,008 shares at $262.00 ($1.3M)
Madsen Julia, Sr. VP and GM, Life Sciences
No 10b5-1 planSold 31.9% of holdings ($4.1M position)10,710 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | STE | Sr. VP and GM, Life Sciences | Form 4 sale | 5,008 | $1.3M | 31.9% | Unusual | SEC |
| Jun 5, 2024 | STE | Senior VP, Life Sciences | Form 4 sale | 3,652 | $840k | 27.4% | Unusual | SEC |
| Apr 23, 2021 | STE | Senior VP, Life Sciences | Form 4 sale | 1,000 | $215k | 17.7% | Plan not stated | SEC |
| Apr 20, 2021 | STE | Senior VP, Life Sciences | Form 4 sale | 1,000 | $210k | 17.7% | Plan not stated | SEC |
| Jan 8, 2021 | STE | Senior VP, Life Sciences | Form 4 sale | 1,000 | $202k | 17.7% | Plan not stated | SEC |
| Nov 9, 2020 | STE | Senior VP, Life Sciences | Form 4 sale | 1,900 | $366k | 29.0% | Unusual | SEC |